CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

This festive season, help us put hope in sight

We need your support to make more sight-saving discoveries possible, bringing hope to people affected by vision loss and blindness.

Your donation will help us advance eye research with real-life impact, taking new technologies from the lab to the eye clinic.

Video

In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.

Research

A world-leading multidisciplinary research project, investigating age-related macular degeneration and the factors that make some people more likely to lose their vision.

Free guide

This free guide gives you an essential introduction to age-related macular degeneration (AMD), and a snapshot of the latest world-leading research at CERA.

Donate to CERA

With your support, there’s hope in sight.

Your gift will contribute to our world-leading vision research, making a real difference to people affected by vision loss and blindness.

Donate now

Take part in research

We conduct world-leading clinical trials for a range of eye conditions.

Learn more about taking part in clinical trials for conditions like age-related macular degeneration, glaucoma, diabetic retinopathy and more.

Learn more

Latest News


News

06 December 2020

CERA glaucoma researcher Dr Jennifer Fan Gaskin will encourage women and girls to aspire to careers in science, technology, engineering and mathematics as part of the 2021 Superstars of STEM program.

Research

05 November 2020

Researchers have used gene therapy to regenerate damaged optic nerve fibres in a discovery that could help treat glaucoma, one of the world’s leading causes of blindness.

Research

28 October 2020

New research at the Centre for Eye Research Australia will tackle the backlog of undiagnosed and untreated eye conditions resulting from missed appointments during the COVID-19 pandemic.

Research

15 October 2020

CERA’s research into the effectiveness of vitamin B3 in preventing nerve cell damage in glaucoma has received a major funding boost from Glaucoma Australia.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals